Sox2 has been implicated to promote invasion, migration, and metastasis in colorectal cancer, glioma, melanoma, gastric cancer, hepatocellular cancer, and ovarian cancer [24,32,33,34,35,36]. Here, SOX2 is linked to ovarian carcinoma.